Pure Global AI
Manufacturer profile

WFR/AQUAPLAST CORPORATION

TaiwanUnited States2 products registeredJan 22, 2009 – Oct 01, 2021
VerifiedTFDA · Taiwan Food and Drug Administration registry
2
Total products
2
Product types
1
Active products
Oct 2021
Latest registration
Company details
Address
30 LAWLINS PARK, WYCKOFF NJ, 07482, U.S.A.
Regulatory footprint
Search WFR/AQUAPLAST CORPORATION across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this manufacturer
“WFR” Aquaplast Splinting Materials (Non-sterile)
Class 1
Oct 01, 2021
"Dafoya" splint raw material (unsterilized)
Class 1
Jan 22, 2009
Most popular products
Products with most registrations
“WFR” Aquaplast Splinting Materials (Non-sterile)
1 registrations
"Dafoya" splint raw material (unsterilized)
1 registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
BOULDER ENTERPRISE CO., LTD.
2 products
Recent registered products
Most recent products (showing top 20)
“WFR” Aquaplast Splinting Materials (Non-sterile)
Registered: Oct 01, 2021 • Expires: Oct 31, 2024
Risk Class
Class 1
Type
MD
AR
BOULDER ENTERPRISE CO., LTD.
"Dafoya" splint raw material (unsterilized)
Registered: Jan 22, 2009 • Expires: Jan 22, 2024
Cancelled
Risk Class
Class 1
AR
BOULDER ENTERPRISE CO., LTD.
About this profile

Explore comprehensive manufacturer profile for WFR/AQUAPLAST CORPORATION based in United States through Pure Global AI's free Taiwan medical device database. This manufacturer has 2 products registered in Taiwan across 2 unique product categories. Their regulatory history spans from Jan 22, 2009 to Oct 01, 2021.

This page provides detailed insights including 2 recent product registrations, 2 most popular products with “WFR” Aquaplast Splinting Materials (Non-sterile) having 1 registrations, and 1 authorized representatives including BOULDER ENTERPRISE CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.